Skip to main content
. 2012 Sep 20;107(9):1518–1524. doi: 10.1038/bjc.2012.416

Figure 4.

Figure 4

PD monitoring of tCK18 and cCK18 in 56 patients with metastatic CRC undergoing conventional chemotherapy, categorised by treatment response. The y axis is percentage change in biomarker. Curves generated using cubic splines knotted at days 3, 14, and 21. Shaded area represents 95% CI.